GCG and amyotrophic lateral sclerosis: Thus, PYY, MCP-1, glucagon, c-peptide, and glucose levels can be evaluated as possible biomarkers for ALS diagnoses and progression as one of the hallmarks of impaired glucose metabolism [30].